(Q47395663)

15 January 2018

reason for preferred rank

title

Follitropin-α versus human menopausal gonadotropin in an in vitro fertilization program (English)

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(03)02188-5

30 March 2024

Follitropin-alpha versus human menopausal gonadotropin in an in vitro fertilization program (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607554

30 March 2024

author name string

Nina Desai

series ordinal

2

1 reference

15 January 2018

James M. Goldfarb

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607554

30 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

15 January 2018

full work available at URL

http://www.fertstert.org/article/S0015028203021885/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607554

https://api.elsevier.com/content/article/PII:S0015028203021885?httpAccept=text/xml

30 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0015-0282(03)02188-5

https://api.elsevier.com/content/article/PII:S0015028203021885?httpAccept=text/plain

30 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0015-0282(03)02188-5

30 March 2024

published in

Fertility and Sterility

1 reference

15 January 2018

volume

80

1 reference

15 January 2018

issue

5

1 reference

15 January 2018

page(s)

1094-1099

1 reference

15 January 2018

Creutzfeldt-Jakob legacy for Australian women treated with human pituitary gonadotropins

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902188-5

Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902188-5

Delayed-type hypersensitivity to human gonadotropin: case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902188-5

Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902188-5

A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902188-5

HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902188-5

Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902188-5

Outcome from consecutive in-vitro fertilization/intracytoplasmic sperm injection attempts in the final group treated with urinary gonadotrophins and the first group treated with recombinant follicle stimulating hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902188-5

Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902188-5

An introduction to Markov modelling for economic evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902188-5

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902188-5

Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902188-5

Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902188-5

Impact of urinary FSH price: a cost-effectiveness analysis of recombinant and urinary FSH in assisted reproduction techniques in the USA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902188-5

7 January 2021

Identifiers

DOI

1 reference

15 January 2018

1 reference

15 January 2018